Global and China GABA Receptor Agonist Drug Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the GABA Receptor Agonist Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Elan Corporation

    • Pfizer

    • Eli Lilly and Company

    • Biocodex

    • XenoPort

    • OVATION Pharmaceuticals

    • HLundBeck, Merck and Co

    • NovaDel Pharma

    • AstraZeneca

    • GlaxoSmithKline

    • sanofi-aventis

    • VIVUS

    • Novartis

    • Athena Drug Delivery Solutions

    • Advicenne

    • Osmotica Pharmaceutical

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Bamaluzole

    • Phenibut

    • Baclofen

    • Gaboxadol

    • Klonopin (clonazepam)

    • Tiagbine

    Application:

    • Attention Deficit Hyperactivity Disorder (ADHD)

    • Psychiatric Disorders and Depression

    • Alzheimer

    • Epilepsy and Seizure

    • Anxiety and Sleep Disorders

    • Obesity and Alcoholism

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 GABA Receptor Agonist Drug Industry Overview

      • 1.1.1 GABA Receptor Agonist Drug Market Scope and Market Segments

      • 1.1.2 GABA Receptor Agonist Drug Industry Characteristics

      • 1.1.3 Global and China GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China GABA Receptor Agonist Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global GABA Receptor Agonist Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Bamaluzole

      • 1.2.2 Phenibut

      • 1.2.3 Baclofen

      • 1.2.4 Gaboxadol

      • 1.2.5 Klonopin (clonazepam)

      • 1.2.6 Tiagbine

    • 1.3 Global GABA Receptor Agonist Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Attention Deficit Hyperactivity Disorder (ADHD)

      • 1.3.2 Psychiatric Disorders and Depression

      • 1.3.3 Alzheimer

      • 1.3.4 Epilepsy and Seizure

      • 1.3.5 Anxiety and Sleep Disorders

      • 1.3.6 Obesity and Alcoholism

    • 1.4 Market Analysis by Region

      • 1.4.1 North America GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global GABA Receptor Agonist Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global GABA Receptor Agonist Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China GABA Receptor Agonist Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China GABA Receptor Agonist Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global GABA Receptor Agonist Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 GABA Receptor Agonist Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 GABA Receptor Agonist Drug Industry PEST Analysis

    • 2.3 GABA Receptor Agonist Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 GABA Receptor Agonist Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on GABA Receptor Agonist Drug Industry

    Chapter 3 Global and China GABA Receptor Agonist Drug Market, by Manufacturer

    • 3.1 Global and China GABA Receptor Agonist Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China GABA Receptor Agonist Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China GABA Receptor Agonist Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China GABA Receptor Agonist Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China GABA Receptor Agonist Drug Market Top 3 Players

    Chapter 4 Global and China GABA Receptor Agonist Drug Market, by Type (2017-2028)

    • 4.1 GABA Receptor Agonist Drug Market Trend, by Type

    • 4.2 Global GABA Receptor Agonist Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global GABA Receptor Agonist Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global GABA Receptor Agonist Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global GABA Receptor Agonist Drug Price Trend, by Type (2017-2028)

    • 4.3 China GABA Receptor Agonist Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China GABA Receptor Agonist Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China GABA Receptor Agonist Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China GABA Receptor Agonist Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China GABA Receptor Agonist Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global GABA Receptor Agonist Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global GABA Receptor Agonist Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global GABA Receptor Agonist Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China GABA Receptor Agonist Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China GABA Receptor Agonist Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China GABA Receptor Agonist Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global GABA Receptor Agonist Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America GABA Receptor Agonist Drug Market Analysis

    • 7.1 North America GABA Receptor Agonist Drug Market, by Type

    • 7.2 North America GABA Receptor Agonist Drug Market, by Application

    • 7.3 North America GABA Receptor Agonist Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe GABA Receptor Agonist Drug Market Analysis

    • 8.1 Europe GABA Receptor Agonist Drug Market, by Type

    • 8.2 Europe GABA Receptor Agonist Drug Market, by Application

    • 8.3 Europe GABA Receptor Agonist Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC GABA Receptor Agonist Drug Market Analysis

    • 9.1 APAC GABA Receptor Agonist Drug Market, by Type

    • 9.2 APAC GABA Receptor Agonist Drug Market, by Application

    • 9.3 APAC GABA Receptor Agonist Drug Market Analysis and Forecast, by Country

      • 9.3.1 China GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa GABA Receptor Agonist Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa GABA Receptor Agonist Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa GABA Receptor Agonist Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa GABA Receptor Agonist Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina GABA Receptor Agonist Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China GABA Receptor Agonist Drug Company Profiles

      • 11.1 Elan Corporation

        • 11.1.1 Elan Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Elan Corporation GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.1.3 Elan Corporation GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Pfizer

        • 11.2.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Pfizer GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.2.3 Pfizer GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Eli Lilly and Company

        • 11.3.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Eli Lilly and Company GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.3.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Biocodex

        • 11.4.1 Biocodex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Biocodex GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.4.3 Biocodex GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 XenoPort

        • 11.5.1 XenoPort Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 XenoPort GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.5.3 XenoPort GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 OVATION Pharmaceuticals

        • 11.6.1 OVATION Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.6.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 HLundBeck, Merck and Co

        • 11.7.1 HLundBeck, Merck and Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 HLundBeck, Merck and Co GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.7.3 HLundBeck, Merck and Co GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 NovaDel Pharma

        • 11.8.1 NovaDel Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 NovaDel Pharma GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.8.3 NovaDel Pharma GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 AstraZeneca

        • 11.9.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 AstraZeneca GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.9.3 AstraZeneca GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 GlaxoSmithKline

        • 11.10.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 GlaxoSmithKline GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.10.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 sanofi-aventis

        • 11.11.1 sanofi-aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 sanofi-aventis GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.11.3 sanofi-aventis GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 VIVUS

        • 11.12.1 VIVUS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 VIVUS GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.12.3 VIVUS GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Novartis

        • 11.13.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Novartis GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.13.3 Novartis GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Athena Drug Delivery Solutions

        • 11.14.1 Athena Drug Delivery Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.14.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Advicenne

        • 11.15.1 Advicenne Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Advicenne GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.15.3 Advicenne GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Osmotica Pharmaceutical

        • 11.16.1 Osmotica Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Profiles, Application and Specification

        • 11.16.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 GABA Receptor Agonist Drug Industry Investment Prospect and Risk Assessment

    • 12.1 GABA Receptor Agonist Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 GABA Receptor Agonist Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Production Value and Growth Rate (2017-2028)

    • Figure China GABA Receptor Agonist Drug Production Value and Growth Rate (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Bamaluzole (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Phenibut (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Baclofen (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Gaboxadol (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Klonopin (clonazepam) (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Tiagbine (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder (ADHD) (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Psychiatric Disorders and Depression (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Alzheimer (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Epilepsy and Seizure (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Anxiety and Sleep Disorders (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Market Size and Growth Rate of Obesity and Alcoholism (2017-2028)

    • Figure North America GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa GABA Receptor Agonist Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China GABA Receptor Agonist Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China GABA Receptor Agonist Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China GABA Receptor Agonist Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China GABA Receptor Agonist Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China GABA Receptor Agonist Drug Market Share, by Manufacturer in 2021

    • Figure Global and China GABA Receptor Agonist Drug Market Share, by Manufacturer in 2022

    • Table Global GABA Receptor Agonist Drug Sales Volume, by Type (2017-2028)

    • Table Global GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Table Global GABA Receptor Agonist Drug Sales Value, by Type (2017-2028)

    • Table Global GABA Receptor Agonist Drug Sales Value Share, by Type (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Price Trend, by Type (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Volume, by Type (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Figure China GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Value, by Type (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Value Share, by Type (2017-2028)

    • Figure China GABA Receptor Agonist Drug Price Trend, by Type (2017-2028)

    • Table Global GABA Receptor Agonist Drug Sales Volume, by Application (2017-2028)

    • Table Global GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Table Global GABA Receptor Agonist Drug Sales Value, by Application (2017-2028)

    • Table Global GABA Receptor Agonist Drug Sales Value Share, by Application (2017-2028)

    • Figure Global GABA Receptor Agonist Drug Sales Value Share, by Application (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Volume, by Application (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure China GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Value, by Application (2017-2028)

    • Table China GABA Receptor Agonist Drug Sales Value Share, by Application (2017-2028)

    • Figure China GABA Receptor Agonist Drug Sales Value Share, by Application (2017-2028)

    • Figure China GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa GABA Receptor Agonist Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America GABA Receptor Agonist Drug Sales Volume, by Type (2017-2028)

    • Table North America GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Table North America GABA Receptor Agonist Drug Sales Volume, by Application (2017-2028)

    • Table North America GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe GABA Receptor Agonist Drug Sales Volume, by Type (2017-2028)

    • Table Europe GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe GABA Receptor Agonist Drug Sales Volume, by Application (2017-2028)

    • Table Europe GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure France GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC GABA Receptor Agonist Drug Sales Volume, by Type (2017-2028)

    • Table APAC GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC GABA Receptor Agonist Drug Sales Volume, by Application (2017-2028)

    • Table APAC GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure China GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure India GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa GABA Receptor Agonist Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa GABA Receptor Agonist Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa GABA Receptor Agonist Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa GABA Receptor Agonist Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina GABA Receptor Agonist Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina GABA Receptor Agonist Drug Sales Value and Growth Rate (2017-2028)

    • Table Elan Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Elan Corporation Product Profiles, Application and Specification

    • Table Elan Corporation GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biocodex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biocodex Product Profiles, Application and Specification

    • Table Biocodex GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table XenoPort Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table XenoPort Product Profiles, Application and Specification

    • Table XenoPort GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table OVATION Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table OVATION Pharmaceuticals Product Profiles, Application and Specification

    • Table OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table HLundBeck, Merck and Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table HLundBeck, Merck and Co Product Profiles, Application and Specification

    • Table HLundBeck, Merck and Co GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NovaDel Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NovaDel Pharma Product Profiles, Application and Specification

    • Table NovaDel Pharma GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table sanofi-aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table sanofi-aventis Product Profiles, Application and Specification

    • Table sanofi-aventis GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table VIVUS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table VIVUS Product Profiles, Application and Specification

    • Table VIVUS GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Athena Drug Delivery Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Athena Drug Delivery Solutions Product Profiles, Application and Specification

    • Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Advicenne Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Advicenne Product Profiles, Application and Specification

    • Table Advicenne GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Osmotica Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Osmotica Pharmaceutical Product Profiles, Application and Specification

    • Table Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.